One day I hope the New Drug Application process can have a monitoring and supervision system as sophisticated as FSD Beta.
Just imagine: Constant 100% always-on supervision, supervision of the supervisors with 3-strikes you're out attentiveness monitoring, automatic and manual reporting of possible anomalies with full system+surroundings snapshots to inform diagnostics and development, immediate feedback of these into the simulations that validate new versions, and staged rollout that starts at smaller N (driving simulators are actually pretty good) and continues intensive monitoring up to larger N. Even Phase 3 trials only involve thousands of people, while FSD beta is driving a million miles per day with monitoring that feels more like Phase 1 or mayyybe Phase 2.
One day drug development will be this sophisticated, and it will be glorious.
Just imagine: Constant 100% always-on supervision, supervision of the supervisors with 3-strikes you're out attentiveness monitoring, automatic and manual reporting of possible anomalies with full system+surroundings snapshots to inform diagnostics and development, immediate feedback of these into the simulations that validate new versions, and staged rollout that starts at smaller N (driving simulators are actually pretty good) and continues intensive monitoring up to larger N. Even Phase 3 trials only involve thousands of people, while FSD beta is driving a million miles per day with monitoring that feels more like Phase 1 or mayyybe Phase 2.
One day drug development will be this sophisticated, and it will be glorious.